The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Gain on disposal of property and equipment | - | 10,804 |
| Net income | 12,833,326 | 23,931,802 |
| Depreciation and amortization expense | 746,211 | 1,264,405 |
| Non-cash lease expense | 1,251,045 | 2,185,744 |
| Provision for (reversal of) credit losses | 22,211 | 283,752 |
| Stock-based compensation | 0 | - |
| Fair value change of long-term investments | 724,476 | -384,523 |
| Gain on disposal of subsidiary | 0 | 0 |
| Gain on redemption of life insurance policies | 8,746,138 | 8,746,138 |
| Loss (gain) on disposal of property and equipment and intangible assets | 414,167 | - |
| Change in fair value of cryptocurrencies | 146,036 | 111,632 |
| Deferred income taxes | 1,651,252 | 7,452,983 |
| Accounts receivable-Nonrelated Party | 294,739 | 789,577 |
| Accounts receivable-Related Party | 10,992,577 | 17,039,113 |
| Inventories | -983,024 | 717,972 |
| Finance lease receivables - related parties | 2,744,645 | 6,482,967 |
| Customer loans receivable | -4,071,560 | -8,081,703 |
| Prepaid expenses and other current assets | 831,470 | 1,349,225 |
| Long-term prepayments | -281,666 | -211,988 |
| Other assets | 8,298 | -85,907 |
| Accounts payable | 1,384,721 | 1,165,217 |
| Accounts payable - related parties | -311,551 | 2,455,865 |
| Notes and other payables - related parties | -7,727,966 | -5,031,570 |
| Advances from customers-Nonrelated Party | 530,781 | -369,616 |
| Advances from customers-Related Party | -3,106,953 | -2,363,891 |
| Income tax payable | -13,905,629 | -6,030,526 |
| Operating lease liabilities | -1,364,489 | -2,275,398 |
| Accrued liabilities and other current liabilities | -1,588,436 | -2,508,035 |
| Other liabilities | -4,548 | -88,593 |
| Net cash provided by (used in ) operating activities | -20,884,258 | -6,411,168 |
| Purchase of property and equipment | 43,053 | 560,431 |
| Purchase of convertible note | 0 | 0 |
| Prepayments for property and equipment | 838,568 | 705,351 |
| Advances to related parties | 0 | 0 |
| Payments made on behalf of related parties | 1,840,801 | 1,836,541 |
| Purchase of long-term investments | 1,515 | 652,555 |
| Purchases of cryptocurrencies | 424,250 | 424,250 |
| Cash paid for acquisition of subsidiary, net of cash acquired | 14,861,858 | - |
| Long-term loans to others | -14,514 | -13,134 |
| Repayments from related parties | 1,841,440 | 70,000 |
| Repayments from others | -73,928 | -56,307 |
| Proceeds from redemption of life insurance policies | 0 | 17,735,717 |
| Disposal of subsidiary, net of cash disposed of | 0 | 0 |
| Proceeds from disposal of property and equipment | 1,027,747 | 1,728,236 |
| Net cash provided by (used in) investing activities | -12,158,475 | 15,397,998 |
| Borrowings from long-term loans | 14,851,980 | - |
| Borrowings from related parties | 0 | 15,000 |
| Proceeds from reverse recapitalization, net of transaction costs | 0 | - |
| Proceeds from exercise of stock warrants | 0 | - |
| Repayments of long-term loans | -647,618 | -74,256 |
| Repayments of finance lease liabilities | 32,506 | 278,097 |
| Repayments to related parties | 18,839 | 27,943 |
| Repurchase of common stock | 2,584,735 | 2,415,262 |
| Deemed contribution in connection with price modification on disposal of property and equipment | 9,682,277 | 9,682,277 |
| Net cash provided by financing activities | 11,568,282 | 6,901,719 |
| Effect of exchange rate changes | -3,835,113 | 11,808,241 |
| Net change in cash and cash equivalents | -25,309,564 | 27,696,790 |
| Cash and cash equivalents at beginning of period | 125,044,092 | - |
| Cash and cash equivalents at end of period | 127,431,318 | - |
SBC Medical Group Holdings Inc (SBCWW)
SBC Medical Group Holdings Inc (SBCWW)